Mandate

Vinge advises Studentbostäder i Norden AB (publ) in connection with its rights issue and written procedure in relation to its notes

Vinge is advising Studentbostäder i Norden AB (publ), a real estate company whose shares are listed on Nasdaq First North Premier Growth Market, in connection with a fully guaranteed rights issue amounting to a total of SEK 331 million before deduction of transaction costs and the amendments to the terms and conditions of the company’s outstanding green 2021/2024 notes with ISIN SE0015960802 (the “Notes”) by way of a written procedure.

The new shares issued by reason of the rights issue are expected to be admitted to trading on Nasdaq First North Premier Growth Market during week 45, 2023.

The amendments to the terms and conditions of the Notes included, among other things, an extension of the final maturity date to 15 November 2026, an amendment of the interest rate to a fixed PIK interest and a new undertaking for the company to partly amortise the Notes.

Studentbostäder I Norden AB (publ) owns, manages and develops student housing in long term partnerships with municipalities, counties and universities. The company’s shares are listed in Sweden on Nasdaq First North Premier Growth Market under the ticker STUDBO.

Vinge’s team consists of Jesper Schönbeck, Joel Wahlberg, Benjamin Vafaeian, Gabriel Chabo and Alexander Rüdén (Capital Markets and Public M&A), Mikael Ståhl, Lionardo Ojeda, Felix Möller and August Ahlin (Banking and Finance).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025